Treatment landscape of triple-negative breast cancer — expanded options, evolving needs von Bianchini, Giampaolo, De Angelis, Carmine, Licata, Luca, Gianni, Luca

Volltext

HER2-positive breast cancer von Loibl, Sibylle, Prof, Gianni, Luca, MD

Volltext

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer von Bardia, Aditya, Hurvitz, Sara A, Tolaney, Sara M, Loirat, Delphine, Punie, Kevin, Oliveira, Mafalda, Brufsky, Adam, Sardesai, Sagar D, Kalinsky, Kevin, Zelnak, Amelia B, Weaver, Robert, Traina, Tiffany, Dalenc, Florence, Aftimos, Philippe, Lynce, Filipa, Diab, Sami, Cortés, Javier, O’Shaughnessy, Joyce, Diéras, Véronique, Ferrario, Cristiano, Schmid, Peter, Carey, Lisa A, Gianni, Luca, Piccart, Martine J, Loibl, Sibylle, Goldenberg, David M, Hong, Quan, Olivo, Martin S, Itri, Loretta M, Rugo, Hope S

Volltext

Hallmarks of triple negative breast cancer emerging at last von Bernardi, Rosa, Gianni, Luca

Volltext

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, op... von Gianni, Luca, Prof, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Starosławska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia Valeria, MD, Magazzù, Domenico, PhD, McNally, Virginia, PhD, Douthwaite, Hannah, MSc, Ross, Graham, FFPM, Valagussa, Pinuccia, BS

Volltext

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis von Cortazar, Patricia, Dr, Zhang, Lijun, PhD, Untch, Michael, Prof, Mehta, Keyur, MBA, Costantino, Joseph P, DrPH, Wolmark, Norman, MD, Bonnefoi, Hervé, Prof, Cameron, David, Prof, Gianni, Luca, Prof, Valagussa, Pinuccia, BS, Swain, Sandra M, MD, Prowell, Tatiana, MD, Loibl, Sibylle, Prof, Wickerham, D Lawrence, MD, Bogaerts, Jan, PhD, Baselga, Jose, Prof, Perou, Charles, PhD, Blumenthal, Gideon, MD, Blohmer, Jens, Prof, Mamounas, Eleftherios P, MD, Bergh, Jonas, Prof, Semiglazov, Vladimir, Prof, Justice, Robert, MD, Eidtmann, Holger, MD, Paik, Soonmyung, MD, Piccart, Martine, Prof, Sridhara, Rajeshwari, PhD, Fasching, Peter A, Prof, Slaets, Leen, PhD, Tang, Shenghui, PhD, Gerber, Bernd, Prof, Geyer, Charles E, MD, Pazdur, Richard, MD, Ditsch, Nina, MD, Rastogi, Priya, MD, Eiermann, Wolfgang, Prof, von Minckwitz, Gunter, Prof

Volltext

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicent... von Gianni, Luca, Dr, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Roman, Laslo, MD, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Staroslawska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia, MD, Szado, Tania, PhD, Ratnayake, Jayantha, BSc, Ross, Graham, MD, Valagussa, Pinuccia, BS

Volltext

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HE... von Gianni, Luca, Dr, Eiermann, Wolfgang, MD, Semiglazov, Vladimir, MD, Lluch, Ana, PhD, Tjulandin, Sergei, MD, Zambetti, Milvia, MD, Moliterni, Angela, MD, Vazquez, Federico, MD, Byakhov, Mikhail J, PhD, Lichinitser, Mikhail, MD, Climent, Miguel Angel, MD, Ciruelos, Eva, MD, Ojeda, Belen, MD, Mansutti, Mauro, MD, Bozhok, Alla, PhD, Magazzù, Domenico, PhD, Heinzmann, Dominik, PhD, Steinseifer, Jutta, PhD, Valagussa, Pinuccia, BS, Baselga, Jose, MD

Volltext

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Th... von BASELGA, José, GELMON, Karen A, FUMOLEAU, Pierre, GIANNI, Luca, VERMA, Shailendra, WARDLEY, Andrew, CONTE, Pierfranco, MILES, David, BIANCHI, Giulia, CORTES, Javier, MCNALLY, Virginia A, ROSS, Graham A

Volltext

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study von PRAT, Aleix, BIANCHINI, Giampaolo, BYAKHOW, Mikhail, BERMEJO, Begoña, ZAMBETTI, Milvia, VAZQUEZ, Federico, GIANNI, Luca, BASELGA, José, THOMAS, Marlene, BELOUSOV, Anton, CHEANG, Maggie C. U, KOEHLER, Astrid, GOMEZ, Patricia, SEMIGLAZOV, Vladimir, EIERMANN, Wolfgang, TJULANDIN, Sergei

Volltext

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer von Blumenthal, Gideon M., Bunn, Paul A., Chaft, Jamie E., McCoach, Caroline E., Perez, Edith A., Scagliotti, Giorgio V., Carbone, David P., Aerts, Hugo J.W.L., Aisner, Dara L., Bergh, Jonas, Berry, Donald A., Jarkowski, Anthony, Botwood, Nicholas, Cross, Darren A.E., Diehn, Max, Drezner, Nicole L., Doebele, Robert C., Blakely, Collin M., Eberhardt, Wilfried E.E., Felip, Enriqueta, Gianni, Luca, Keller, Steven P., Leavey, Patrick J., Malik, Shakun, Pignatti, Francesco, Prowell, Tatiana M., Redman, Mary W., Rizvi, Naiyer A., Rosell, Rafael, Rusch, Valerie, de Ruysscher, Dirk, Schwartz, Lawrence H., Sridhara, Rajeshwari, Stahel, Rolf A., Swisher, Stephen, Taube, Janis M., Travis, William D., Keegan, Patricia, Wiens, Jacinta R., Wistuba, Ignacio I., Wynes, Murry W., Hirsch, Fred R., Kris, Mark G.

Volltext

Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01) von DE AZAMBUJA, Evandro, PROCTER, Marion J, JACKISCH, Christian, CAMERON, David A, BELL, Richard, LEYLAND-JONES, Brian, DOWSETT, Mitch, GELBER, Richard D, PICCART-GEBHART, Martine J, SUTER, Thomas M, VAN VELDHUISEN, Dirk J, AGBOR-TARH, Dominique, METZGER, Otto, STEINSEIFER, Jutta, UNTCH, Michael, SMITH, Ian E, GIANNI, Luca, BASELGA, Jose

Volltext

Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-... von Krop, Ian E, Suter, Thomas M, Dang, Chau T, Dirix, Luc, Romieu, Gilles, Zamagni, Claudio, Citron, Marc L, Campone, Mario, Xu, Na, Smitt, Melanie, Gianni, Luca

Volltext

Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2 + Breast Cancer von Hanker, Ariella B, Estrada, Mónica Valeria, Bianchini, Giampaolo, Moore, Preston D, Zhao, Junfei, Cheng, Feixiong, Koch, James P, Gianni, Luca, Tyson, Darren R, Sánchez, Violeta, Rexer, Brent N, Sanders, Melinda E, Zhao, Zhongming, Stricker, Thomas P, Arteaga, Carlos L

Volltext

Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation von Gaviraghi, Marco, Rabellino, Andrea, Andolfo, Annapaola, Brand, Matthias, Brombin, Chiara, Bagnato, Paola, De Feudis, Giuseppina, Raimondi, Andrea, Locatelli, Alberta, Tosoni, Daniela, Mazza, Davide, Gianni, Luca, Tonon, Giovanni, Yarden, Yosef, Tacchetti, Carlo, Daniele, Tiziana

Volltext

Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor,... von GIANNI, Luca, LLADO, Anna, HERSBERGER, Veronica, BASELGA, José, BIANCHI, Giulia, CORTES, Javier, KELLOKUMPU-LEHTINEN, Pirkko-Liisa, CAMERON, David A, MILES, David, SALVAGNI, Stefania, WARDLEY, Andrew, GOEMINNE, Jean-Charles

Volltext

Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European... von GIANNI, Luca, BASELGA, José, BOZHOK, Alla, MARTINEZ-AGULLO, Angel, GRECO, Marco, BYAKHOV, Mikhail, LOPEZ LOPEZ, Juan Josè, MANSUTTI, Mauro, VALAGUSSA, Pinuccia, BONADONNA, Gianni, EIERMANN, Wolfgang, GUILLEM PORTA, Vincente, SEMIGLAZOV, Vladimir, LLUCH, Ana, ZAMBETTI, Milvia, SABADELL, Dolores, RAAB, Günther, LLOMBART CUSSAC, Antonio

Volltext

Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma von Reni, Michele, Peretti, Umberto, Zanon, Silvia, Macchini, Marina, Balzano, Gianpaolo, Mazza, Elena, Tamburrino, Domenico, Orsi, Giulia, Arcidiacono, Paolo Giorgio, Falconi, Massimo, Gianni, Luca

Volltext

Role of Anthracyclines in the Treatment of Early Breast Cancer von GIANNI, Luca, NORTON, Larry, WOLMARK, Norman, SUTER, Thomas M, BONADONNA, Gianni, HORTOBAGYI, Gabriel N

Volltext

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer von Gianni, Luca, Zambetti, Milvia, Clark, Kim, Baker, Joffre, Cronin, Maureen, Wu, Jenny, Mariani, Gabriella, Rodriguez, Jaime, Carcangiu, Marialuisa, Watson, Drew, Valagussa, Pinuccia, Rouzier, Roman, Symmans, W Fraser, Ross, Jeffrey S, Hortobagyi, Gabriel N, Pusztai, Lajos, Shak, Steven

Volltext